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Effects of Soybean Flour on the
Pancreas of Rats
by Eileen E. McGuinness,* Reginald G. H. Morgant and
Kenneth G. Wormsley*
We have reviewed the growth-promoting and carcinogenic effects offeeding raw soya flour to rats. Ifthe
raw soya flour-containing diets are fed for more than a year, about 10% of the animals develop pancreatic
cancer. In addition, feedingraw soya flour markedly potentiates the action ofeven subthreshold amounts of
pancreatic carcinogens. The raw soya flour therefore acts as a potent promoter, as well as a weak
carcinogen. In view of this promotion, the rat fed raw soya flour is a sensitive model for screening
pancreatic carcinogens.
It is notknown whetherthe human pancreas respondstodietarytrypsin inhibitors in amanner similarto
the rat. However, in view of the use of soya-based products in human nutrition-especially in infant
foods-we urge that the effect of all soya-based products intended for human use be tested on the rat
pancreas in long-term feeding studies, combined with subthreshold doses of azaserine to highlight any
promoting activity ofthe product. It seems probable that ifa product exerts no effect on the rat pancreas,
the human pancreas will also be spared from noxious effects.
Morphological Aspects
Macroscopic Features
Raw soya flour-containing diets have been shown to
produce enlargement of the rat pancreas after admin-
istration for as little as 10 to 20 days (1). The pancreatic
enlargement has been shown toreflect bothhypertrophy
(defined as increase in cellular size and amount of
protein per unit of DNA) (2) and also hyperplasia
(increase in the amount of DNA and number ofcells in
the gland) (3). We have shown that the pancreatic
growth-promotingeffects continue, iftheadministration
of raw soya flour is maintained, but becomes progres-
sively more marked in an exponential manner at some
time between 30 and 60 weeks of feeding raw soya
flour-containing diets (4).
During the period of pancreatic enlargement, the
gland changes color to become dark red, reflecting
increased vascularity and blood flow, as demonstrated
by use of microspheres (unpublished results).
Some time between 24 and 30 weeks after the start of
raw soya flour-containing diets, small greyish patches
become visible on the surface of the gland. Subse-
quently, overt nodules appear and increase in size
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throughout the gland as the duration ofexposure to the
raw soya flour increases (4). The increased size of the
nodules correlates with the exponential phase of
increase in size and weight of the gland.
After administration ofraw soya flour for more than
60 weeks, the pancreas becomes progressively more
likely to develop carcinomatous change (4). About half
the carcinomas spread to involve the liver, some clearly
as a result of metastases.
Ten to fifteen percent of rats develop pancreatic
cancer, ifthe rats are continuously fed raw soya flour in
amounts ranging from 5 to 100% ofthe total protein of
the diet (with unicellular protein making up the
remainder). Theproportionofratsdevelopingpancreatic
cancer is greater (up to 60%) in rats fed 100% raw soya
flour for only 2 days each week for 60 weeks or more,
with non-soya-containing chow for the remaining 5 days
each week (4). Allthese values ofincidence ofpancreatic
cancer are significantly greater than the maximal value
of about 1% of "spontaneous" pancreatic neoplasms
recorded in the literature (5), particularly bearing in
mind that this value has been obtained from observa-
tions on rats fed "routine" diets, which have probably
contained soya flour.
Our rats receiving diets free from soya flour have not
developed abnormal foci, nodules, or pancreatic cancer.
Similarly, rats receiving heated soya flour do not show
abnormal increase in pancreatic weight during feeding
for 2 years (4). Although a few microscopic and
macroscopic nodules developed after feeding heatedMcGUINNESS ET AL.
soya flour for 60 weeks or more, no animal fed heated
soya flour developed pancreatic cancer (4).
Microscopic Appearances
Within 1 to 2 days after starting a diet containing raw
soya flour, the rat pancreas shows patchy necrosis of
isolated pancreatic acinar cells and acini, but this
damage is rapidly resolved. If the animals continue to
receive raw soya flour, further morphological changes
occur, including enlargement of cells and acini, with
increased zymogen content (6). These changes correlate
with the growth of the gland and with the increased
secretory response to stimulants of the pancreas of
these animals (7).
After feeding raw soya flour-containing diets for 16 to
24 weeks, a few microscopic foci can be found scattered
throughout the pancreas. The number and size of the
nodules increases with the duration offeeding (4). The
microscopic nodules are initially composed of acinar
cells, containing zymogen granules, with more eosino-
philic cytoplasm than the surroundingunaffected acinar
tissue. The nuclei are larger and less dense and mitotic
figures are much more commonthaninthe surrounding,
apparently normal, acinar tissue. When the nodules
become larger, the acinar cells often appear to be
arrangedintubularfashion. Thesurroundingpancreatic
cells may appear to becompressed. The nodules become
well defined and, after about one year of feeding raw
soya flour, become separated from the surrounding
pancreatic cells by a fibrous capsule. Islets of Langer-
hans are not seen within the nodules.
After a year or more of raw soya flour-containing
diets, a part ofthe nodule may dedifferentiate with loss
of zymogen granules and cytoplasm and crowding of
nuclei. The appearances may suggest the development
of a nodule within a nodule. Ultimately, the nuclei and
cells become pleomorphic and invasion ofthe capsule or
spread outside the capsule indicates overtly malignant
transformation.
When azaserine is administered to rats fed raw soya
flour, a higher yield of nodules and more rapid pro-
gression to carcinoma occurs (see below). In these
animals, the microscopic appearances of the cancers
range from well-differentiated acinar cell neoplasms
(44%) to papillary (26%) or undifferentiated (30%) car-
cinomas. The metastatic lesions in the liver show a sim-
ilar rangeofappearances, withwell-differentiated lesions
predominant.
Reversibility of Morphological Changes
The pancreatic weights, protein content and morph-
ological appearances revert to normal when rats are fed
raw soya flour for 5 days (8), 4 weeks (9) and 6 months
(unpublished observations) and then receive non-soya-
containing diets.
If rats are fed raw soya flour for as long as 6 months
and the diet is then changed to non-soya-containing
chow, nodules are not found at death a year or more
later, so that histologically the pancreas of these rats
resembles the morphological appearances of the pan-
creas ofanimals fed non-soya-containing diets through-
out life. It seems that nodule formation can be re-
versed and, indeed, the development of pancreatic
cancer prevented since even continuing azaserine does
not result in pancreatic cancer in animals in which raw
soya flour is discontinued after 12 weeks (10). Adminis-
tration of raw soya flour for longer than 6 months
results in irreversible nodule formation and progression
to pancreatic carcinoma, despite change to non-soya
flour-containing diets (unpublished observations).
Mechanisms of Promotion of
Pancreatic Growth
The mechanisms whereby raw soya flour stimulates
pancreatic growth and neoplastic transformation have
not been defined. However, it has been proposed that
raw soyaflour, which containsproteaseinhibitors (1,11),
acts on the pancreas indirectly by inhibiting trypsin
within the lumen of the small intestine (12). Intra-
luminal trypsin is considered to inhibit pancreatic
secretion by inhibiting the release of a stimulant hor-
mone such as cholecystokinin by a "negative feedback"
mechanism (13,14). As a consequence oftryptic inhibi-
tion by soybean trypsin inhibitor, there is therefore
unfettered release ofthe pancreatic stimulant hormone
(15) from the small intestinalmucosa. Administration of
raw soya flour to rats does result in marked increase in
the concentration of circulating cholecystokinin (16),
and cholecystokininhasbeenshownto stimulatepancre-
atic hypertrophy and hyperplasia in rats (17,18). It has
therefore been concluded that continuous release of
large amounts ofcholecystokinin during feeding ofraw
soya flour is responsible for the pancreatic growth.
However, other factors in raw soya flour are probably
alsoinvolvedinrawsoyaflour-inducedpancreaticgrowth
(19), since it has been calculated that as little as 40% of
the enlargement of the rat pancreas produced by the
ingestion of raw soybeans is accounted for by the
trypsin inhibitor (20). The remainder may, in part,
reflect the presence of undenatured soybean protein,
which can itself bind trypsin. In addition, free fatty
acids can produce trypsin inhibition (21), a finding
which may explain the "promoting" effects both of
heated soya flour (22) and high fat diets (23,24) on
pancreatic carcinogenesis in rats.
Other mechanisms may also be operative. For ex-
ample, soya bean flour adsorbs bile salts (25). Since
cholestyramine, which adsorbs bile salts, also causes
pancreatic hypertrophy and hyperplasia in, rats (26),
deficiency of intestinal intraluminal bile salts may be
involved in the stimulation ofpancreatic growth, either
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directly or indirectly by limiting the absorption of free
fatty acids from the intestinal lumen.
Cellular Kinetic Studies
DNA and RNA Content
Within a day of starting administration of soybean
trypsin inhibitor, an increase occurs in the total
pancreatic RNA and protein content ofthe neonatal rat
(27). An increase in pancreatic DNA content occurs as
early as 48 hr in the neonatal rats (27), but we have
found that in youngadult animals, totalpancreatic DNA
is not significantly increased until between the first and
second week after starting to feed raw soya flour.
Pancreatic DNA content then increases to plateau levels
after 4 to 8 weeks ofthe raw soya flour diet and remains
significantly raised as long as the animals are kept on
the diet (3). However, these indices ofgrowth have only
been studied systematically during36weeks ofraw soya
flour-containing diets, and it is therefore not known
whether DNA content rises exponentially, as does
pancreatic weight, after this time. Pancreatic weight
and DNA content increase only slowly and only in
parallel with body weight between 8 and 36 weeks after
start of the raw soya diet. It has been shown that the
newborn rat is particularly sensitive to the trophic
effects of raw soya flour on the pancreas (27), and the
cessation of growth in older rats might therefore be
attributed to failure of the mature rat pancreas to
respond to the growth stimulation provided by feeding
raw soya flour. However, feeding raw soya flour to
1-year-old rats previously fed non-soya-containing chow
resulted in a trophic response at least as vigorous as
that seen in young animals, with an increase in DNA
content similar to the 140% increase reported in the
young adult animals (3). The leveling off ofgrowth and
DNA content of the pancreas after 4 to 8 weeks of the
raw soya flour diet is thus not caused by the agingofthe
rats. Thefactorsinvolved inthebluntingoftheresponse
to the (presumably) continued trophic stimulus have not
been further defined.
An increase in total pancreatic DNA is usually
interpreted asindicatinghyperplasia (increased number
ofcells). This interpretation is correct only ifthe DNA
content of individual cells does not change. In rats fed
raw soya flour for prolonged periods, increasing var-
iability innuclearsize andstaining occurs. Itispossible,
therefore, that some of the changes in DNA content
may be caused by changes in ploidy of a population
of acinar cells. Recent measurement of nuclear DNA
in acinar cells isolated from rats fed raw soya flour indi-
cates that there is indeed an increased percentage
of tetraploid cells in these animals (unpublished ob-
servations).
The pancreatic content of DNA and RNA remains
significantly increased during feeding ofraw soya flour.
After feeding raw soya flour for four weeks, DNA
content is increased by one-third compared with control
rats and pancreatic weight, RNA and protein content
are double the control values of animals fed non-soya
diets. Ifthe diet is then changed to heated soya flour or
non-soya-containing chow, the DNA content reverts to
control values within 48 hr, while pancreatic weight,
RNA and protein content return to normal values
within 1 week (9). This rapid involution is associated
with surprisingly little morphological evidence oftissue
destruction, though patchy apoptotic changes are seen.
Animals undergoing this reversion to normal morph-
ological appearances never seem distressed and no
deaths have occurred in 50 animals during change to a
non-soya-containing diet.
Indices of Cellular Replication
When rats are fed raw soya flour, pancreatic cell
turnover is increased for the first 8 weeks ofthe diet, as
shown by the incorporation of 3H-thymidine into
pancreatic DNA both in vivo (28) (unpublished obser-
vations) and invitro (29). Nochangeis seenwithin24 hr
of starting to feed raw soya flour, but a marked
stimulation of DNA synthesis then occurs, peaking at
about ten times that seen in control animals, 40 to 48 hr
after starting the diet. The synthesis of DNA then
decreases to control values after 5 to 7 days, before
risingagaintoabroadpeakofincreased DNAsynthesis,
about five times that found in control animals, between
11/2 and 3 weeks after starting the raw soya diet. The
synthesis ofDNA then slowly declines, to reach control
values after about 8 weeks and thereafter remains at
control levels (Fig. 1).
Autoradiographic studies show that both acinar and
centroacinar cells are labeled during the early peak,
with acinar cells responding first. It appears, therefore,
that at least some ofthe new cells produced as a result
of feeding raw soya flour are derived from apparently
mature acinar cells, but the relative contribution from
SPECIFIC ACTIVrTY EXPRESSED AS A RATIO OP CONTROL
6 7
WEEKS
FIGURE 1. Specific activity of pancreatic DNA after 30 min of in
vitro incubation with 3H-thymidine. The activity in animals fed
raw soya flour is expressed as a ratio of the activity in control
animals fed heated soya flour (trypsin inhibitorinactivated) forthe
same period. Results are the mean ofthree assays on each offour
or eight rats (29).
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this source and from the centroacinar or duct cells has
not yet been defined. During the later peak, duct cell
labeling predominates. It has been suggested that the
uncommitted pancreatic stem cell is morphologically
similar to the centroacinar cell, so that these labeled
cells may be the precursor ofboth duct and acinar cells
in the enlarged gland (30).
Both the in vivo and in vitro studies show that
after 8 weeks of raw soya flour diet, cell turnover has
returned to values not greater than those observed in
rats fed non-soya chow or heated soya flour. The latter
finding is in accord with the observation that in these
animals, mitotic activity is very low in apparently
normal pancreatic tissue surrounding the hyperplastic
foci. However, mitoses are common in the developing
foci and this proliferative activity increases with the
length of exposure to raw soya flour and the progression
ofthe nodules. Cellular kinetics inthefocihave notbeen
systematically investigated, but we have demonstrated
increased cell turnover in nodules in in vitro studies,
during which the incorporation of 3H-thymidine into
DNA was measured in enucleated nodules and in the
surrounding tissue from rats fed raw soya flour for 52
weeks. In the three animals studied, the specific activ-
ity ofDNA from the nodules was 12, 6 and 10 times that
of the surrounding tissue (29), indicating a marked
increase in the rate of cell turnover in the nodules,
compared with the surrounding normal tissue.
Effect of Additional
Carcinogens
It has previously been reported (31) that replicating
tissues are more sensitive to carcinogens than cells
which are kineticallyinert. We have therefore tested the
effect of administering exogenous carcinogens to rats
fed soya-derived and control diets.
Azaserine (O-diazoacetyl-L-serine), a derivative of
serine (32) obtained from Streptomyces fragilis, has
been shown to produce persistent DNA damage (33),
nodule formation and, after administration for a year or
more, pancreatic cancer in rats (34). We have shown
rapid andmarked potentiationbetween adietcontaining
raw soya flour and azaserine in as little as 24 weeks (35).
While raw soyaflourdiets and azaserine singlyproduced
only a few microscopic pancreatic nodules in a few rats
during this period, the combined administration of a
raw soya flour-containing diet and azaserine resulted in
the development ofmultiple nodules in all animals (35).
Subsequent studies showed that azaserine, in a dose of
5 mg/kgbody weight each week, given intraperitoneally
for 60 weeks, produced a few microscopic and macro-
scopic nodules in the rat pancreas but never resulted in
pancreatic cancer if the rats were fed non-soya-
containing diets (prepared with monocellular (yeast)
protein as the source of protein). Azaserine (5 mg/kg)
was therefore subcarcinogenic for the rat pancreas (22).
Nevertheless, the administration of this subthreshold
dose of azaserine induced pancreatic cancer in more
than 60% of rats fed raw soya flour for more than 60
weeks (10). The potentiating effects ofraw soya flour on
the development ofazaserine-induced pancreatic cancer
also occurred when the raw soyaflourwas administered
only after the end of a 3-week course of 5 mg/kg-week
azaserine (unpublished) but if, alternatively, raw soya
flour-containing diets were given for only 12 weeks, no
pancreatic cancer developed in the rats given azaserine
for as long as 60 weeks (10). A higher dose (15 mg/kg
each week) ofazaserine has produced pancreatic cancer
in our rats, irrespective ofdiet (unpublished). Previous
reports that 5 mg/kg each week of azaserine produced
cancer (34) in rats fed commercial chow may reflect
strain differences of may be attributable to different
composition ofthe diet fed to the rats, since commercial
rat chows have contained considerable amounts of soya
proteins.
We have also studied the effect of a nitrosamine
derivative, di(2-hydroxypropyl)nitrosamine, on the de-
velopment ofpancreatic cancerinrats fed raw soyaflour
(36). This nitrosamine had been reported to be only
weakly carcinogenic for the pancreas of rats (37). We
confirmed that when the nitrosamine was administered
to rats receiving non-soya diets, no pancreatic cancer
developed while pancreatic cancer did occur in treated
animals fed raw soya flour (36). We concluded that, as
with azaserine, the feedingofraw soyaflourpotentiated
the effects on the rat pancreas of an exogenous
carcinogen.
While no rats fed non-soya-containing diets and given
subthreshold doses of azaserine developed more than a
few microscopic nodules (22), the administration of
azaserine to rats fed heated soya flour resulted in the
development of pancreatic cancer in nearly 40% of
animals (22). Heated soyaflourthus alsopotentiates the
carcinogenic effects ofazaserine. It is possible that the
fat content of our preparation of heated flour has been
responsible, in part, for this potentiation, since it has
subsequently been shown that 20% unsaturated fat in
the diet of rats receiving azaserine increases the
incidence of pancreatic cancer (23,24).
A further example ofpotentiation which is, however,
rather more difficult to interpret comprises the finding
that 60% ofrats which survived an attack ofethionine-
induced pancreatitis and were subsequently fed raw
soya flour-containing diet developed pancreatic cancer.
The combination ofethionine pancreatitis and raw soya
flour diet therefore potentiated in a manner similar to
the combination ofazaserine and raw soya flour (38). In
this case, ethionine may act as a pancreatic carcinogen
-as it has been shown to act as a hepatic carcinogen
(39)-with the production of initiated cells either as a
direct result ofthe ethionine or during the hyperplastic
response to pancreatic damage.
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Implications for Evaluation of
Pancreatic Carcinogenesis
Processes Involved in Carcinogenesis
It seems probable that a chemical such as azaserine is
a typical genotoxic pancreatic carcinogen, which is
capable of initiating carcinogenesis when administered
in subthreshold doses but also of producing overt
pancreatic cancer when given in larger doses. Raw soya
flour promotes the pancreatic carcinogenic effects of
azaserine, an effect best illustrated by the finding that
when raw soya flour is administered following a course
of as little as 5 mg/kg azaserine weeklyforonly 3 weeks,
pancreatic cancerdevelops in the treated rats. However,
raw soya flour, like many other promoters, also seems
capable of producing pancreatic carcinoma when ad-
ministered alone for a sufficiently long period, although
it is not possible to exclude the possibility that even in
this case some unidentified environmental carcinogen
has been promoted. Whatever the nature of the
mechanism of raw soya flour-induced pancreatic car-
cinogenesis, the effects are exerted throughout the
gland. As with other pancreatic carcinogens (40), foci of
phenotypically altered cells develop in all parts of the
pancreas. The mitotic activity ofthe cells in these foci is
abnormally increased, suggesting that these cells are
either more susceptible to the continuing hormonal
drive provided by feeding raw soya flour, or less
sensitive to normal inhibition of continuing pancreatic
growth.
The lifespan of the neoplastically altered cells is
probably shortened, as evidenced by the considerable
degree of apoptosis within the foci. These foci, at all
stages of development, must be considered neoplastic
rather than "hyperplastic," and depend for further
growth and frankly malignant change only on the
presence of a promoter. Promotion is provided by
dietary factors such as raw soya flour and probably fats.
The raw soya flour acts especially powerfully if applied
regularly but intermittently, rather than continuously.
It seems that the drive to cellular replication within the
neoplastic foci is greater with intermittent stimulation
ofgrowth, followed byrest, thanbycontinuous exposure
to the (hormonal) growth-producing stimulus. Perhaps
in the latter situation (of continuous exposure to
cholecystokinin) there is down-regulation of the chol-
ecystokinin receptors, or desensitization (41) of the
neoplastic cells, while cells exposed intermittently are
not subject to receptor loss and do not lose functional
(proliferative) capacity.
It is not yet clear how the association between
ethionine-induced pancreatitis and the augmented
incidence of pancreatic cancer is to be interpreted.
Either the ethionine is acting as a genotoxic pancreatic
carcinogen, which is promoted by raw soya flour, or the
initiation provided by raw soya flour is promoted by the
repair processes in the pancreas following ethionine
pancreatitis.
With othermodels ofexperimental pancreatic cancer,
there has been considerable discussion about the
nomenclature and significance of the aggregates of
phenotypically abnormal cells which occur and develop
during the course of time (40). It seems to us that, in
this model at least, there is no real distinction between
different stages of "foci," "nodules" and "adenomata"
regarding potential for development into frank car-
cinoma. "Reversibility" of the smaller aggregates of
cells presumably merely reflects the tendency of these
cells to become phenotypically (and functionally) more
"normal" if the stimulus to growth (provided by a
promoter or promoting situation) is removed. However,
the cells have been "initiated" and therefore remain
potentiallyprecursorsofpancreaticcancerifthegrowth-
promoting circumstances recur.
Screening of Carcinogens
Potentiation of the effects of subcarcinogenic effects
ofazaserine provides a very sensitive model for testing
or screening for other genotoxic carcinogens. Since, like
azaserine, this type of pancreatic carcinogen must be
givenin very large doses in orderto permit development
of pancreatic cancer, it seems probable that the
promotion provided by raw soya flour will permit
detection of potential carcinogens in much smaller
dosage. It is, of course, essential to quantitate the
numbers ofneoplastic foci within the pancreas in order
to detect early potentiation (35). In longerterm studies,
it becomes necessary to differentiate between the
effectsofthepotentiated carcinogenandthebackground
proliferation evoked by the promoting raw soya flour.
Under these circumstances, more elaborate morph-
ometric techniques are required to determine the
amount of pancreatic tissue replaced by abnormally
proliferating masses of cells (42,43). In view of the
likelihood that under normal conditions man is rarely
exposed to very large amounts of carcinogens, we
consider that screening for environmental pancreatic
carinogens with sensitized (promoter-fed) animals is
much more likely to reflect normal environmental
circumstances and therefore to permit identification of
chemical agents which have potential carcinogenic risk
for human (as well as rat) pancreas. Earlier studies,
using single chemicals without promotion (44) may
therefore not have been sufficiently sensitive to detect
possible genotoxic pancreatic carcinogens. A possible
example is the failure to identify ethionine as a
pancreatic carcinogen in non-soya chow-fed animals.
Just as the raw soya flour-fed rat has a pancreas
which is admirably sensitive for testing genotoxic
carcinogens, so the rat which has been given a
subcarcinogenic dose ofazaserine is suitable for screen-
ing epigenetic (promoting) carcinogens, since this type
ofcarcinogen will act like raw soya flour in potentiating
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the development of pancreatic cancer in appropriately
treated rats.
Testing Anti-Cancer Drugs and Regimes
In view of the high yield of neoplastic foci, nodules
and carcinomata in rats given azaserine and fed raw
soya flour, therapeutic agents or dietary regimes with
potential activity against pancreatic cancer can be
tested for efficacy on all stages of pancreatic carcin-
ogenesis. For example, using melphalan, we found no
rats with pancreatic cancer in animals fed raw soyaflour
for more than 60 weeks (compared with an incidence of
12% in rats not receiving melphalan).
Role of Dietary Factors in Pancreatic
Carcinogenesis in Rats
The promoting and weak carcinogenic effects of raw
soya flour must be taken into account when testing
chemicals for pancreatic carcinogenic effects. In this
connection, some of the commercially available rat
chows contained raw soyaflourwhenoriginally tested (3
yr ago). It is also necessary to bear in mind that
apparently "spontaneous" nodules may reflect the
presence of carcinogens in the environment of the
animals. For example, N-nitrosamines have been found
in animal feeds and bedding (45).
Implications for Potential
Human Pancreatic Cancer
Nothing is known about the effects of soybean prod-
ucts on the human pancreas, nor to what extent (ifany)
ourmodel ofexperimental pancreatic carcinomareflects
human pancreatic carcinogenesis, either theoretically
or in fact. The matter is clearly important, in view of
the worldwide increase in the incidence of pancreatic
cancer (46) and the potential significance of animal
models for identifying environmental factors which are
etiologically important in the genesis of human cancer
(47-49).
Soybean derivatives, in various forms (50-53), are
used widely in human nutrition. Soybean trypsin in-
hibitors can inhibit human trypsin and chymotrypsin
(54), and it seems possible that man shows negative
feedbackcontrol ofpancreatic secretion (and, therefore,
possibly pancreatic growth) like the rat (unpublished
observations). Ifthis is the case, it is important that all
soya products for human consumption be tested for
their effects on pancreatic growth in the rat. The effect
oflong-term feeding oftextured soya proteins, used as
meat expanders, on the rat pancreas has been studied
by the manufacturers, but the results are not readily
available. This, and related types ofinformation, should
be published.
Two population groups may be particularly at risk if
soyabean products containingactive protease inhibitors
affect the human pancreas in a manner similar to the
rat. One is the adult group of patients suffering from
hyperlipoproteinaemia, in whom soybean protein-
containing diets (in which soybean protein replaces all
animal protein) are used in order to reduce blood levels
ofcholesterol. This type ofpatient could be exposed to a
relatively high intake of trypsin inhibitor.
The other group comprises infants, who are often fed
soya-containingproducts. Inparticular, cowmilk-allergic
infants may subsist on soya-derived milk for many
months (55). The magnitude of the potential problem
can be gauged from the estimate of 10,000 to 30,000
infants supposedly suffering from allergy to cows' milk
in the USA per annum (56).
It has been stated (57) that over 85% of the original
content oftrypsininhibitorofraw soyaflouris destroyed
during heat treatment ofthe soy protein used in milks.
It has also been reported that when a soy protein
preparation was administered to rats for 3 weeks, no
histological changes were observed in the pancreas and
pancreatic weights were similar to those resulting from
administration of a diet in which casein was the source
of protein.
We have studied the trypsin-inhibitory content ofsoy
milks. Two points require emphasis. We have confirmed
that casein has anti-tryptic properties (58) and that
some, at least, of the trypsin-inhibitory effects can be
found in cow milk-derived infant formulae (Fig. 2).
Since casein elicits discharge of pancreatic enzymes
when administered to rats (while albumin does not) (59)
in a manner perhaps similar to raw soya flour, it seems
probable that casein should not be used as "control"
protein when studying the nutritional or carcinogenic
effects of soybean protein. Indeed, it seems possible
that cow milk may promote pancreatic carcinogenesis in
rats given subthreshold amounts of an exogenous
carcinogen (60).
We have found that soya milks (two preparations)
pg Human Trypsin Inhibited
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FIGURE 2. Inhibition of human trypsin by two preparations of soy
milkand two preparations derived fromcows' milk, as well as fresh
cows' milk. Human breast milk did not show inhibitory activity
Method of assay as in (65). The dotted lines indicate extrapolated
values below the sensitivity of the method.
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containtrypsin-inhibitoryactivitywhichisnotdestroyed
by heat and which is active against human trypsin (as
found in duodenal aspirate after stimulation of the
healthy pancreas with secretin and cholecystokinin)
(unpublished observations) (Fig. 2). Heat may not
destroy the protease inhibitors ofsoybean extracts (61)
and, indeed, a finding similar to ours indicates that
'resterilisation' doesnot significantlyreducetheresidual
soybean trypsin-inhibitory activity (57). Some of the
heat resistance of the trypsin inhibitors may be
attributable tothe presence oftherelatively heat-stable
Bowman-Birkinhibitor, whichisalsorelativelyresistant
to degradation by gastric juice (62). Control studies
with human breast milk showed no trypsin-inhibitory
activity. The trypsin-inhibitory contentofthe amount of
soy milk powder recommended for one feed was
sufficient to inhibit the tryptic activity ofabout40 mgof
(adult) human trypsin.
That soy milks may have effects on the pancreas of
human infants can be inferred from a recent report
which has shown that stimulation with cholecystokinin
increases the enzymic activities of duodenal aspirate
from infants fed soya milk, but not from infants fed cow
milk (63). The latter results cannot be satisfactorily
interpreted in terms of pancreatic function (since only
enzymic activities, and not outputs, were measured)
but if the reported results do reflect enzymic outputs,
then the soy milks mayindeed be actingin man asinthe
rat.
Unfortunately, we have not been able to obtain
facilities for testing the effect of soy milks on the rat
pancreas. Our results have been presented to the
manufacturers of soy milks and other products and to
appropriate national regulatory authorities. However,
since the bearing (if any) which soy-related pancreatic
carcinogenesis in the rat has on human disease is not
known, no regulatory action can be specified at the
present time. The general problems underlying govern-
mental control of food safety have been reviewed
previously (64). We would strongly urge that extensive
feeding studies be undertaken in rats, not only of soy
milks and other products, but also of these materials
combinedwithsubthreshold amountsof, e.g., azaserine,
since it seems probable that ifthere is no effect on the
rat pancreas, no noxious effect will be exerted on the
human pancreas either.
KGW gratefully acknowledges the generous support of the Cancer
ResearchCampaign. RGHMacknowledgesthesupportoftheNational
Health and Medical Research Council of Australia and the Cancer
Council of Western Australia.
REFERENCES
1. Rackis, J. J. Physiological properties ofsoybeantrypsininhibitors
and their relationship to pancreatic hypertrophy and growth
inhibition of rats. Fed. Proc. 24: 1488-1493 (1965)
2. Yanatori Y, and Fujita, T. Hypertrophy and hyperplasia in the
endocrine and exocrine pancreas of rats fed soybean trypsin
inhibitor orrepeatedly injected with pancreozymin. Arch. Histol.
Japon. 39: 67-78 (1976).
3. Crass, R. A., and Morgan, H. G. H. The effect of long-term
feeding of soya-bean flour diets on pancreatic growth in the rat.
Brit. J. Nutr. 47: 119-129 (1982).
4. McGuiness, E. E., Morgan, R. G. H., Levison, D. A., Frape,
D. L., Hopwood, D., andWorrnsley, K. G. Theeffectsoflong-term
feedingofsoyaflourontheratpancreas. Scand.,J. Gastroenterol.
15: 497-502 (1980).
5. Roe, F. J. C., and Roberts, J. D. B. Tumours ofthe pancreas. In:
Pathology of Tumours in Laboratory Animals. Vol. I-Thmours
ofthe Rat. Part I (V S. Turusov, Ed.), International Agency for
Research on Cancer, Lyon, 1973, pp. 141-143.
6. Folsch, U. R., Winckler, K., and Wormsley, K. G. Effect of a
soybean diet on enzyme content and ultrastructure of the rat
exocrine pancreas. Digestion 11: 161-171 (1974).
7. F61sch, U. R., and Wormsley, K. G. The pancreatic secretion of
enzymes in rats treated with soybean diet. Scand. J. Gastro-
enterol. 9: 679-683 (1974).
8. Booth, A. N., Robbins, D. J., Ribelin, W E., DeEds, F, Smith,
A. K., and Rackis, J. J. Prolonged pancreatic hypertrophy and
reversibility in rats fed raw soybean meal. Proc. Soc. Exptl. Biol.
Med. 116: 1067-1069 (1964).
9. Crass, R. A., and Morgan, R. G. H. Rapid changes in pancreatic
DNA, RNA and protein in the rat during pancreatic enlargement
and involution. Internat. J. Vit. Nutr. Res. 51: 85-91 (1981).
10. McGuinness, E. E., Hopwood, D., and Wormsley, K. G. Further
studies ofthe effects ofraw soyaflour on the rat pancreas. Scand.
J. Gastroenterol. 17: 273-277 (1982).
11. Wolf, W J. Physical and chemical properties ofsoybean proteins.
J. Am. Oil Chemists Soc. 54: 112A-117A (1977).
12. Green, G. M., and Lyman, R. L. Feedbackregulation ofpancreatic
enzyme secretion as a mechanism for trypsin inhibitor-induced
hypersecretion in rats. Proc. Soc. Exptl. Biol. Med. 140: 6-12
(1972).
13. Green, G. M., Olds, B. A., Matthews, G., and Lyman, R. L.
Protein, as a regulator ofpancreatic enzyme secretion in the rat.
Proc. Soc. Exptl. Biol. Med. 142: 1162-1167 (1973).
14. Ihse, I., Lilja, R, and Lundquist, I. Trypsin as a regulator of
pancreatic secretion in the rat. Scand. J. Gastroenterol. 14:
873-880 (1979).
15. Khayambashi, H., and Lyman, R. L. Secretion of rat pancreas
perfused with plasma from rats fed soybean trypsin inhibitor.
Am. J. Physiol. 217: 646-651 (1969).
16. Adrian, T. E., Pasquali, C., Pescosta, F, Bacarese-Hamilton, A.J.,
and Bloom, S. R. Soya induced pancreatic hypertrophy and
rise in circulating cholecystokinin. Gut 23: A889 (1982).
17. Folsch, U. R., Winckler, K., and Wormsley, K. G. Influence of
repeated administration of cholecystokinin and secretin on the
pancreas ofthe rat. Scand. J. Gastroenterol. 13: 663-671 (1978).
18. Johnson, L. R. Effects ofgastrointestinal hormones on pancreatic
growth. Cancer 47: 1640-1645 (1981).
19. Naim, M., Gertler, A., and Birk, Y. The effect ofdietary raw and
autoclaved soya-bean protein fractions on growth, pancreatic
enlargement and pancreatic enzymes in rats. Brit. J. Nutr. 47:
281-288 (1982).
20. Liener, I. Significance for humans ofbiologically active factors in
soybeans and other food legumes. J. Am. Oil Chemists Soc. 56:
121-129 (1979).
21. Doell, B. H., Ebden, C. J., and Smith, C. A. Trypsin inhibitor
activity of conventional foods which are part of the British diet
and some soya products. Plant Foods Human Nutrition 31:
139-150 (1981).
22. McGuinness, E. E., Morgan, R. G. H., Levison, D. A., Hopwood,
D., and Wormsley, K. G. Interaction of azaserine and raw soya
flour on the rat pancreas. Scand. J. Gastroenterol. 16: 49-56
(1981).
23. Roebuck, B. D., Yager, J. D., and Longnecker, D. S. Dietary
modulation ofazaserine-induced pancreatic carcinogenesis in the
rat. Cancer Res. 41: 888-893 (1981).
24. Roebuck, B. D., Yager, J. D., Longnecker, D. S., andWilpone, S. A.
Promotion by unsaturated fat of azaserine-induced pancreatic212 McGUINNESS ET AL.
carcinogenesis in the rat. Cancer Res. 41: 3961-3966 (1981).
25. Calvert, G. D., and Yeates, R. A. Adsorption of bile salts by
soya-bean flour, wheat bran, lucerne (Medicago sativa), sawdust
and lignin; the effect of saponins and other plant constituents.
Brit. J. Nutr. 47: 45-52 (1982).
26. Brand, S. J., and Morgan, R. G. H. Stimulation of pancreatic
secretion and growth in the rat after feeding cholestyramine.
Gastroenterology 83: 851-859 (1982).
27. Melmed, R. N., El-Aaser, A. A. A., and Holt, S. J. Hypertrophy
and hyperplasia ofthe neonatal rat exocrine pancreas induced by
orally administered soybean trypsin inhibitor. Biochim. Biophys.
Acta 421: 280-288 (1976).
28. Oates, P S., and Morgan, R. G. H. Pancreatic growth and cell
turnover in the raw soyaflourfed rat. Am. J. Pathol. 108: 217-224
(1982).
29. Douglas, A. The effects of raw soya flour on pancreatic cell
turnover. B.Sc. (Hons) Thesis, University of Western Australia.
30. Adler, G., Hupp, T., and Kern, H. F Course and spontaneous
regression of acute pancreatitis in the rat. Virch. Arch. Pathol.
Anat 382: 31-47 (1979).
31. Ryser, H. J.-P Chemical carcinogenesis. New Engl. J. Med. 285:
721-734 (1971).
32. IARC. Some Naturally Occurring Substances. (Monographs on
the Evaluation ofCarcinogenic Risk ofChemicals to Man. Vol. 10)
International Agency for Research on Cancer, Lyon, 1976, pp.
73-77.
33. Lilja, H. S., Curphey, T. J., Yager, J. D., and Longnecker, D. S.
Persistence of DNA damage in rat pancreas following admin-
istration of three carcinogens and/or mutagens. Chem.-Biol.
Interact. 22: 287-295 (1978).
34. Longnecker, D. S., Roebuck, B. D., Yager, J. D., Lilja, H. S., and
Siegmund, B. Pancreatic carcinoma in azaserine-treated rats:
induction, classification and dietary modulation of incidence.
Cancer 47: 1562-1572 (1981).
35. Morgan, R. G. H., Levison, D. A., Hopwood, D., Saunders, J. H.
B., and Wormsley, K. G. Potentiation ofthe action ofazaserine on
the rat pancreas by raw soya bean flour. Cancer Letters 3: 87-90
(1977).
36. Levison, D. A., Morgan, R. G. H., Brimacombe, J. S., Hopwood,
D., Coghill, G., and Wormsley, K. G. Carcinogenic effects of
di(2-hydroxypropyl) nitrosamine (DHPN) in male Wistar rats:
promotion ofpancreatic cancer by a raw soya flour diet. Scand. J.
Gastroenterol. 14: 217-224 (1979).
37. Mohr, U., Reznik, G., and Pour, P Carcinogenic effects of
diisopropanolnitrosamine inSprague-Dawley rats. J. Natl. Cancer
Inst. 58: 361-364 (1977).
38. McGuinness, E. E., Hopwood, D., and Wormsley, K. G.
Potentiation of pancreatic carcinogenesis in the rat by DL
-ethionine-induced pancreatitis. Scand. J. Gastroenterol. 18:
189-192 (1983).
39. Farber, E. Carcinoma of the liver in rats fed ethionine. Arch.
Pathol. 62: 445-453 (1956).
40. Longnecker, D. S. Experimental pancreatic carcinogenesis. Lab.
Invest. 46: 543-544 (1982).
41. Barlas, N., Jensen, R. T., and Gardner, J. D. Cholecystokinin-
induced restricted stimulation of pancreatic enzyme secretion.
Am. J. Physiol. 242: G464-G469 (1982).
42. Weibel, E. R. Principles and methods forthe morphometric study
of the lung and other organs. Lab. Invest. 12: 131-155 (1963).
43. Pugh, T. D., King, J. H., Koen, H., Nychka, D., Chover, J.,
Wahba, G., He, Y H., and Goldfarb, S. Reliable stereological
method for estimating the number of microscopic hepatocellular
foci from their transections. Cancer Res. 43: 1261-1268 (1983).
44. Milman, H. A., Ward, J. M., and Chu, K. C. Pancreatic
carcinogenesis and naturally occurring pancreatic neoplasms of
rats and mice in the NCI carcinogenesis testing program. J.
Environ. Pathol. Toxicol. 1: 829-840 (1978).
45. Silverman, J., and Adams, J. D. N-Nitrosamines in laboratory
animal feed and bedding. Lab. Animal Sci. 33: 161-164 (1983).
46. Morgan, R. G. H., and Wormsley, K. G. Cancer of the pancreas.
Gut 18: 580-596 (1977).
47. Rall, D. P The role of laboratory animal studies in estimating
carcinogenic risks for man. In: Carcinogenic Risks. Strategies for
Intervention (W Davis and C. Rosenfeld, Eds.), International
Agency for Research on Cancer, Lyon, 1979, pp. 179-205.
48. Tomatis, L. The predictive value ofrodent carcinogenicity tests in
the evaluation ofhuman risks. Ann. Rev. Pharmacol. Toxicol. 19:
511-530 (1979).
49. Saffiotti, U. Identification and definition ofchemical carcinogens:
review ofcriteria and research needs. J. Toxicol. Environ. Health
6: 1029-1057 (1980).
50. Wolf, W J. Soybean proteins: their production, properties, and
food uses. A selected bibliography. J. Am. Oil Chemists Soc. 51:
63A-66A (1974).
51. Greuell, E. H. M. Some aspects of research in the application of
soy proteins in foods. J. Am. Oil Chemists Soc. 51: 98A-127A
(1974).
52. Rackis, J. J. Soybean protein: uses, problems, and potential. J.
Am. Oil Chemists Soc. 54: 290A-294A (1977).
53. Young, V R., Scrimshaw, N. S., Torun, B., and Viteri, F Soybean
protein in human nutrition: an overview. J. Am. Oil. Chemists
Soc. 56: 110-120 (1979).
54. Krogdahl, A., and Holm, H. Inhibition of human and rat
pancreatic proteinases by crude and purified soybean proteinase
inhibitors. J. Nutr. 109: 551-558 (1979).
55. Thomson, W A. B. Infant formulas and the use of vegetable
protein. J. Am. Oil Chemists Soc. 56: 386-388 (1979).
56. Anderson, S. A., Chinn, H. I., and Fisher, K. D. History and
current status ofinfant formulas. Am. J. Clin. Nutr. 35: 381-397
(1982).
57. Churella, H. R., Yao, B. C., and Thomson, W A. B. Soybean
trypsin inhibitor activity ofsoy infant formulas and its nutritional
significance for the rat. J. Agr. Food Chem. 24: 393-397 (1976).
58. Flavin, D. F The effects of soybean trypsin inhibitors on the
pancreas of animals and man: a review. Vet. Hum. Ibxicol. 24:
25-28 (1982).
59. Green, G. M. Failure ofintestinally-infused bovine serum albumin
to stimulate pancreatic secretion in the rat. Fed. Proc. 42: 894
(1983).
60. Hoch-Ligeti, C. Primary pancreatic tumours in rats fed p-di-
methyl-aminoazobenzene. Brit. J. Cancer 3: 285-288 (1949).
61. Baintner, K. Trypsin-inhibitor andchymotrypsin-inhibitor studies
with soybean extracts. J. Agr. Food Chem. 29: 201-203 (1981).
62. Krogdahl, A., and Holm, H. Soybean proteinase inhibitors and
human proteolytic enzymes: Selective inactivation ofinhibitorsby
treatment with human gastric juice. J. Nutr. 111: 2045-2051
(1981).
63. Lebenthal, E., Choi, T. S., and Lee, P C. The development of
pancreatic function in premature infants after milk-based and
soy-based formulas. Pediatr. Res. 15: 1240-1244 (1981).
64. Hutt, P B. Unresolved issues in the conffict between individual
freedom and government control of food safety. Food Drug
Cosmetic Law J. 33: 558-589 (1978).
65. Kakade, M. L., Rackis, J. J., McGhee, J. E., and Puski, G.
Determination of trypsin inhibitor activity of soy products: a
collaborative analysis ofanimprovedprocedure. Cereal Chem. 51:
376-382 (1974).